A DESCRIPTIVE STUDY OF PROSTATE LESIONS IN LARGEST HOSPITAL IN ONDO STATE OF NIGERIA
Keywords:
Annual Rectal Examination, Benign Prostatic Hyperplasia, Nodular Hyperplasia, Prostate Cancer, Prostatits, Hematoxylin and EosinAbstract
Purpose: The study aims to retrospectively examine the association between benign prostatic hyperplasia and cancer of the prostate in the largest hospital in Ondo State of Nigeria.
Methodology: A descriptive, cross sectional design was used. A total of 286 prostate biopsies were received, processed and analyzed between 2014 and 2018. Necessary information and data generated were retrieved from histopathology request forms, patients’ registers and result cards. The concerned section slides were retrieved and reviewed. The research instrument used was the Hematoxylin and Eosin [H&E] staining technique. The photomicrograph of the slides was done in the histopathology laboratory, federal medical centre, Owo using a digital microscope camera attached to an Olympus binocular microscope by placing each slide on the microscope stage well focused for a good capturing and better contrast.
Findings: All cases of benign prostatic hyperplasia accounted for 32.2%, nodular hyperplasia was 29.7%, prostate cancers encountered was 30.7% while other lesions accounted for 7.4%. It was found out that prostate cancer affects most men as they get older which leads to urinary problems like those with BPH and prostatitis. They explained that prostate cancer rarely causes symptoms before age 40, but more than half of men in their 60s and most men in their 70s and 80s will have signs of prostate cancer. It was also found out that the occurrence of prostate cancer tended to elevate with increasing age and there was a tendency for the proportion of moderate or severe cases to increase with aging in men.
Unique contribution to theory, practice and policy: The study has contributed to knowledge on the high incidence of prostate lesions in Owo, Ondo State. The awareness created by the study should be used to form policy on yearly prostate screening and annual rectal examination of males between 35 to 65 years of age should be carried out since surgical cure could be done before the cells growth leads to a chronic stage.
Downloads
References
Alexander R.B., Mann D.L, Borkowski, A.A., Fernandez-Vina M, Klyushnenhova, E.N, & Kodak, J. (2014). Granulomatous prostatitis linked to HLA-DRB1. Journal of Urology, 171:2326-2329
Andersson, K.E., Groat, W.C., McVary, K.T., Lue, T.F., Maggi M, & Roehrborn C.G., (2011). Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn. 30 (3): 292-301.
Andrews C, & Humphrey P.A., (2014). Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue. American Journal of Surgical Pathology 38: 1007–1012.
Arista-Nasr J, Martinez-Benitez B, Aguilar-Ayala EL, Aleman-Sanchez CN, Bornstein-Quevedo L, & Albores-Saavedra J. (2015). Pseudohyperplastic prostate carcinoma: Histologic patterns and differential diagnosis. Annual Journal of Diagnostic Pathology 19: 253–260.
Bechis, S.K, Carroll P.R, & Cooperberg, M.R., (2011). Impact of age at diagnosis on prostate cancer treatment and survival. Journal of Clinical Oncology, 29: 235-41
Briganti, A., Salonia, A., Gallina, A., Chun, F., Karakiewicz, P., & Graefen, M., (2007). Management of erectile dysfunction after radical prostatectomy in 2007. World Journal of Urology, 25 (2);143-148.
Brookman-May SD, Campi R, Henriquez J, Klatte T, Langenhuijsen J.F., & Brausi M, (2018). Latest Evidence on the Impact of Smoking, Sports, and Sexual Activity as Modifiable Lifestyle Risk Factors for Prostate Cancer Incidence, Recurrence, and Progression: A Systematic Review of the Literature by the European Association of Urology Section of Oncological Urology (ESOU). European Urology Focus.
Clemens, J.Q, Meenan, R.T, Keeffe, O., Rosetti, M.C., Kimes T., & Calhoun E. A., (2007). Prevalence of and Risk Factors for Prostatitis: Population Based Assessment. Using Physician Assigned Diagnoses. The Journal of Urology; 178: 1333-1337.
Dai X, Fang X, Ma Y, & Xianyu J., (2016). Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies. Medicine (Baltimore), 95: e3493
Etienne M, Chavanet P, Sibert L, Michel F, Levesque H, & Lorcerie B, (2008). Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis. BMC Infectious Disease, 8, 12
Hampton, T., (2006). New virus linked to prostate cancer. JAMA, 295(13), 1503.
Kim, S.H, Ha, U.S, Yoon, B.I, Kim, S.W, Sohn, D.W, & Kim, H.W, (2014). Microbiological and clinical characteristics in acute bacterial prostatitis according to lower urinary tract manipulation procedure. Journal of Infection Chemotherapy, 20: 38-42.
Konig J.E, Senge T., Allhoff, E.P., & Konig, W., (2004). Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer. Prostate 58:121–9.
Kramer, G. & Marberger, M, (2006). Could Inflammation be a key component in the progession of benign prostatic hyperplasia? Current Opinions in Urology, 16: 25–29.
Kryvenko, O.N, Jankowski, M., Chitale, D.A, Tang, D., Rundle, A., & Trudeau S, (2012). Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer, 25, 1023-1032
Lei, Z., Yi, W., Zhiqiang, Q., Xian, G., Qianwei, X., Ran, L., Wei, W., Ninghong S., & Wei Z., (2020). Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis. Journal of Cancer, 11 (1); 177-189
Nair-Shalliker, V, Yap, S, Nunez, C., Egger, S., Rodger, J., & Patel, M.I., (2017). Adult body size, sexual history and adolescent sexual development, may predict risk of developing prostate cancer: Results from the New South Wales Lifestyle and Evaluation of Risk Study. International Journal of Cancer, 140: 565-74.
Nickel, J.C., (2006). Opioids for chronic prostatitis and interstitial cystitis: lessons learned from the 11th World Congress on Pain. Urology, 68 (4):697– 701.
Nickel, J.C., (2008). Inflammation and Benign Prostatic Hyperplasia. Urology Clinical of North America 35 (1): 109–115.
Nickel, J.C, Elhilali, M. & Vallancien G., (2005). Benign prostatic hyperplasia (BPH) and prostatitis: Prevalence of painful ejaculation in men with clinical BPH, 95:571–4.
Pages, S.T., Lin, D.W., Mostaghel, E.A., Hess, D.I., & True, L.D., (2006). Persistence intraprostatic androgen concentration after medical castration in health men. Journal of Clinical Endocrinology Metabolism 91, 3850-3853.
Perdana, N.R., Mochtar, C.A., Umbas, R, & Hamid, A.R., (2016) The Risk Factors of Prostate Cancer and Its Prevention: A Literature Review. Acta Med Indones, 48: 228-238
Rebbeck T.R., (2017). Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography. Seminar on Radiation Oncology, 27: 3-10.
Schaeffer, A.J., (2006). Chronic prostatitis and the chronic pelvic pain syndrome. New England Journal Medicine, 355 (16), 1690–1698.
Starnes, D., & Sims, T. (2006). Care of the patient undergoing robotic-assisted prostatectomy. Urologic Nursing, 26 (2), 129-136.
St. Sauver J.L, Jacobson D.J, McGree M.E, Girman, C.J, Lieber, M.M., & Jacobsen, S.J., (2008) Longitudinal Association between Prostatitis and Development of Benign Prostatic Hyperplasia. Urology; 71: 475-479.
Taoka, R, & Kakehi, Y., (2017). The influence of asymptomatic inflammatory prostatitis on the onset and progression of lower urinary tract symptoms in men with histologic benign prostatic hyperplasia. Asian Journal of Urology, 4: 158-63.
Wallner, L.P., Clemens, J.Q., & Sarma, A.V., (2009). Prevalence of and risk factors for prostatitis in African American men: The Flint Men's Health Study. The Prostate. 69: 24-32.
Weiss, L.M., Loera, S., & Bacchi, C.E., (2010). Immunoglobulin light chain immunohistochemistry revisited, with emphasis on reactive follicular hyperplasia versus follicular lymphoma. Applied Immunohistochemistry Molecular Morphology, 18: 199–205
Downloads
Published
How to Cite
Issue
Section
License
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
